Navigation Links
Lucian Leape Institute First Roundtable: A Resounding Success
Date:2/12/2008

Roundtable and Open Discussions Held in Conjunction with Inaugural Gala

NORTH ADAMS, Mass., Feb. 12 /PRNewswire/ -- The Lucian Leape Institute at the National Patient Safety Foundation held its first Roundtable meeting and Inaugural Gala February 7-8, 2008 at the Westin Copley Place in Boston, Massachusetts. The Institute, established by NPSF in May 2007, is a think tank charged with defining strategic paths and calls to action for the field of patient safety. Its goal is to provide vision and context for the many safety-related efforts already underway within the healthcare system and to call for system-level changes necessary to accelerate the work. Its Founding Members include Dr. Leape, Dr. David Lawrence, Julianne Morath, Dr. Donald Berwick, Dr. Carolyn Clancy, James Conway and Dr. Dennis O'Leary, all of whom are renowned leaders in the patient safety field.

The first Roundtable was held on February 7 and was focused on further development of the Institute's inaugural report on transformational concepts for the field. Following the formal Roundtable session, the Founding Members facilitated five separate Open Discussions on February 8 with more than 300 attendees to share their perspectives and provide their input to the work. The five areas of discussion addressed included Health Professions Education; Consumer Involvement; Integrating Healthcare Organizations; Transparency; and Joy and Meaning in Work. The final report summarizing the Roundtable and the Open Discussions will be presented at NPSF's annual Congress in May.

To celebrate the establishment of the Institute and the beginning of its work, the Institute also hosted its Inaugural Gala on the evening of February 8, following the conclusion of the first Roundtable and the Open Discussions. Nearly 400 attendees enjoyed a festive evening feting Dr. Leape and acknowledging his accomplishments and the contributions of all the Founding Members of the Institute.

Leadership Spo
'/>"/>

SOURCE National Patient Safety Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Lucian Leape Institute Announces First Roundtable
2. Statement by Gerald Leape, Vice President, Marine Conservation, National Environmental Trust, on a New Recommendation From Scientists Urging Pregnant Women to Eat More Fish
3. Spencer Institute Announces Wellness Coaching: Innovative Certification Training for Life Coaching
4. MITs McGovern Institute honors Emory neuroscientist for contributions to psychiatry
5. The Institute for Plastination Responds to the Bishop of Manchesters Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester
6. Ludwig Institute for Cancer Research receives NHMRCs largest 2009 grant
7. Lifestyle Fitness Coaching Becomes the Next Revolution in Fitness for Spencer Institute
8. MITs McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia
9. Novel vaccine concept developed by scientists at the Wistar Institute
10. Genetics Researcher at Childrens Hospital Selected as Howard Hughes Medical Institute Investigator
11. Genetics researcher at Childrens Hospital selected as Howard Hughes Medical Institute Investigator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...ment. What do you remember about your breakfast th... smell of coffee brewing, while another will remem...r. How does the brain weave together these fragmen...ife? , Researchers led by Prof. Itzhak Fried, a ...lty of Medicine, are proving scientifically what s...
(Date:12/4/2008)...ird of Americans with diabetes do not know that th...ditions are unaware that they are at risk. A Univ...al tool to identify those at highest risk for havi...ose (IFG) and undiagnosed diabetes. If these condi...rom preventative strategies that can minimize prog...
(Date:12/4/2008)...c. 4 Triple-S,Managemen...it has signed a non-,binding letter of intent to ...zul de Puerto Rico, Inc. In addition, the Company...transfer the licensing rights to the Blue Cross br...ield brands in the US Virgin Islands,to the Compa...
(Date:12/4/2008)...work(TM) to Administer Program , , BUFFALO,...inder(TM) Network has been selected by The Washing...r a Medication Therapy Management (MTM) program fo...UMP) and the Aetna Public Employees Plan of Washin...mmunity pharmacists to review prescriptions with p...
Breaking Medicine News(10 mins):Health News:Unlocking the mysteries of memory 2Health News:Researcher develops screening tool to identify patients with prediabetes 2Health News:Triple-S Management Corporation Signs Letter of Intent to Acquire Managed Care Portfolio of La Cruz Azul de Puerto Rico, Inc. 2Health News:Washington State Health Care Authority to Launch Medication Therapy Management Initiative 2
...n babies and birth weight, it has been found that ...creased liking for salt.// The results of the pres...uals include more salt in their diet than others. ...lthy babies, weighing atleast 2.5 kg. These babies...
... of mothers who are obese before pregnancy or who ...ming overweight at a very young age//. The resea...s the children get older, in a research paper publ.... Dr. Pamela J. Salsberry and Dr. Patricia B. Re...
...ronique Roger, M.D., M.P.H., at the Mayo Cardiolog...e is a high risk of these patients suffering from ...ke risk was 44 times more during the 30 day period...ents when compared to the normal person. The study...
...om color blindness due to X-chromosome variations,...olors but have an increased sensitivity to differe... be differentiated by normal persons. The results ...llon and colleagues, University of Cambridge had b...
Other Medicine News:Health News:Birth Weight of Babies Important Predictor for Salt Preference 2Health News:Kids of overweight mothers have higher obesity risk 2Health News:Colorblind Individuals have expanded color vision 2
(Date:12/3/2008)... Pa., Dec. 3 Wyeth Pharm...nnounced today that it has submitted a,marketing ...dicines Agency,(EMEA) for approval to market its ...vaccine (PCV13) for infants and young children. W...of pneumococcal disease (PD) caused by the 13,ser...
(Date:12/2/2008)... 3 Researchers using fu...uitry in the area of the brain,responsible for su...ering from,stress-related psychiatric disorders. ...he annual meeting of the Radiological Society of N...major depression and other stress-related disorder...
(Date:12/2/2008)... Dec. 2 Horizon Therapeutics, Inc....ay announced that two pivotal,Phase 3 trials eval... HZT-501,met all primary endpoints. HZT-501, a n...containing ibuprofen and famotidine, demonstrated ...dence of non-steroidal,anti-inflammatory drug (NS...
(Date:12/1/2008)...c. 1 TargeGen has announced that a...a multi-center, US-based clinical,trial of TG1013... scheduled at,the 2008 American Society of Hemato...entation are as follows:, Title: ...ble, JAK2-Selective Inhibi...
Breaking Medicine Technology:Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac 28TM 29 Development at Prestigious International Sympos 2209 1Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac 28TM 29 Development at Prestigious International Sympos 2209 2Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac 28TM 29 Development at Prestigious International Sympos 2209 3Looking tired or angry may have more to do with facial aesthetics than how you feel 20399 1Looking tired or angry may have more to do with facial aesthetics than how you feel 20399 2Oregon Cosmetic Vein Center Opens in Portland Among First on West Coast to Offer Brand New FDA Approved Procedures and Technologies 20397 1Oregon Cosmetic Vein Center Opens in Portland Among First on West Coast to Offer Brand New FDA Approved Procedures and Technologies 20397 2Oregon Cosmetic Vein Center Opens in Portland Among First on West Coast to Offer Brand New FDA Approved Procedures and Technologies 20397 3Buyers Health Care Action Group Pilots New Bridges to Excellence Program for Depression 20395 1Buyers Health Care Action Group Pilots New Bridges to Excellence Program for Depression 20395 2Buyers Health Care Action Group Pilots New Bridges to Excellence Program for Depression 20395 3
...Mar 7, 2007 - Accentia,Biopharmaceuticals, Inc. (N...l Meeting of the American Academy of Allergy, Asth...San Diego, CA. The,posters discussed findings from...rgists in the U.S., U.K., France, and Germany on t... and attitudes of,the fungal etiology of CS, and t...
...r 7, 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel,s l...e-clinical data from trials of BL-1040 demonstrati...ration of the myocardium,after a myocardial infarc...ion and eventual heart failure in a pig model. Pro...Cardiac Research,Institute at Sheba Medical Center...
Other Medicine Technology:Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th
Triad Plus PVP-I Scrub swabsticks is formulated with an antimicrobial surgical cleanser containing to prevent dryness. It contains 7.5% PVP-I, USP solution equivalent to 0.75% available iodin
...are saturated with a 10% Povidone Iodine, USP ...vidone Iodine is virtually non-irritating to skin,...g to the skin or natural fabrics. Our swabsticks n...tools for removing small particles from wounds, su...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness.
Medicine Products: